Atlas Trials

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

Clinical trial NCT07660939 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07660939
Sponsor
Peking University First Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Plasma Cell DisordersMultiple Myeloma (MM)
Start date
2026-06-25
Primary completion
2027-05-25
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.